These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3521035

  • 1. [Use of bone scintigraphy in the evaluation of bone involvement by prostatic cancer treated with a LHRH-antiandrogen combination].
    Lacourcière Y, Dupont A, Giguère M, Labrie F.
    Union Med Can; 1986 Apr; 115(4):229-34. PubMed ID: 3521035
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate.
    Labrie F, Belanger A, Dupont A, Emond J, Lacoursiere Y, Monfette G.
    Lancet; 1984 Nov 10; 2(8411):1090. PubMed ID: 6150154
    [No Abstract] [Full Text] [Related]

  • 4. Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents.
    Schally AV, Redding TW, Paz-Bouza JI, Comaru-Schally AM, Mathe G.
    Prog Clin Biol Res; 1987 Nov 10; 243A():173-97. PubMed ID: 2889215
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of combined androgen blockade for advanced prostate cancer in British Columbia.
    Chau A, de Lemos ML, Pickles T, Blood P, Kovacic L, Abadi S, Barnett J.
    J Oncol Pharm Pract; 2010 Jun 10; 16(2):121-6. PubMed ID: 19541764
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oncological outcomes of hormonal therapy with a gonadotropin-releasing hormone agonist combined with a steroidal or non-steroidal antiandrogen in patients with prostate cancer.
    Igawa T, Tsurusaki T, Nomata K, Hayashi M, Furukawa M, Sakai H.
    Anticancer Res; 2014 Apr 10; 34(4):1983-8. PubMed ID: 24692735
    [Abstract] [Full Text] [Related]

  • 12. Quantitative bone scintigraphy in the survey of bone-seeking cancers.
    Grob JC, Lallot C, Methlin G, Bollack C.
    Prog Clin Biol Res; 1990 Apr 10; 348():187-94. PubMed ID: 2385606
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Leuprolide therapy for prostate cancer. An association with scintigraphic "flare" on bone scan.
    Johns WD, Garnick MB, Kaplan WD.
    Clin Nucl Med; 1990 Jul 10; 15(7):485-7. PubMed ID: 2116949
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy.
    Rigaud J, Tiguert R, Le Normand L, Karam G, Glemain P, Buzelin JM, Bouchot O.
    J Urol; 2002 Oct 10; 168(4 Pt 1):1423-6. PubMed ID: 12352409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.